Edward (Jed) A. Gordon advises clients regarding strategic portfolio development and counsels them in relation to patent enforcement strategies and defense against threatened patent infringement litigation. Jed has drafted and prosecuted patent applications in the fields of computer networking, wireless networking, video displays, medical devices, speech processing, MEMS devices, business methods, semiconductor processing, optical devices, video surveillance and software.
Jed also provides transactional counseling in relation to intellectual property issues arising during the acquisition and sale of privately and publicly owned companies. In addition to managing due diligence for private equity and strategic acquisitions and early stage investments, Jed is regularly called upon to lead the complex negotiations of IP provisions necessary to implement cross-border joint ventures and other strategic collaborations. He has supported deals across a wide range of industries, including in the automotive, nuclear power, medical device, computing and telecommunications, health care, and consumer products industries.
While in law school, Jed was a contributing editor for the Michigan Law Review. He also participated in the Jessup International Law Moot Court.
Education
University of Michigan Law School, JD, cum laude, 2002
Massachusetts Institute of Technology, BS, Computer Science, Electrical Engineering and Science, Technology and Society, 1999
Admissions
Massachusetts
Courts / Agencies
US Patent and Trademark Office
Partner | Boston
Boston: +1 617 535 3987
Boston: +1 617 535 3800
Cambridge, MA / McDermott Event / March 20, 2019
Cambridge, Massachusetts / McDermott Event / September 12, 2018
Burlington, Massachusetts / McDermott Event / February 13, 2018
Boston, Massachusetts / Speaking Engagements / January 25, 2018
1
Washington, DC / Accolades & Rankings / June 14, 2019
IAM Patent 1000 Recognizes McDermott Team for Creative Strategies, Clarity of Purpose and ...
Accolades & Rankings / June 13, 2018
McDermott Recognized by IAM Patent 1000 Among Leading Patent Law Practitioners
Boston / Press Releases / January 18, 2018
McDermott Advises Mitsubishi Heavy Industries in Connection with the Reorganization of the ...
Boston / Le Monde du Droit / January 9, 2018
The National Law Journal / December 5, 2017
Lawyers Say Fed. Regulators Likely Will Closely Scrutinize Aetna-CVS Deal
The Lawyer / December 4, 2017
The New York Times / December 4, 2017
McDermott Multidisciplinary Team Advises CVS in Acquisition of Aetna
The Deal Pipeline / December 4, 2017
MSN Money / December 4, 2017
CVS to acquire Aetna for $69 billion in year's largest acquisition
The Deal Pipeline / December 4, 2017
The Wall Street Journal / December 3, 2017
McDermott Multidisciplinary Team Advises CVS in Acquisition of Aetna as Reported By ...
Fox Business / December 3, 2017
Law360 / December 3, 2017
The Financial Times / December 3, 2017
Düsseldorf / Accolades & Rankings / June 20, 2017
McDermott Maintains Strong Position as a Leading Firm in IAM Patent 1000
The National Law Journal / July 18, 2016
Chicago / Accolades & Rankings / July 13, 2016
McDermott Maintains Rankings as a Leading Patent Firm in IAM Patent 1000 2016
Life Sciences Intellectual Property Review / July 4, 2016
The Am Law Daily / June 27, 2016
Boston / Press Releases / June 20, 2016
IP Frontline / June 20, 2016
Law360 / June 20, 2016
1
2
3
4
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
